1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Osteogenesis Imperfecta Type IV: new trials by email Literature Review of Osteogenesis Imperfecta Type IV trials Research Report on Osteogenesis Imperfecta Type IV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804 setrusumab, Calcium, Vitamin D - Osteogenesis Imperfecta, Type I, Osteogenesis Imperfecta Type III | Phase 2 | Completed | Ultragenyx Pharmaceutical Inc | 112 | 2017-09-11 | 2023-07-05 |
Osteogenesis Imperfecta (1) · Osteogenesis imperfecta, type 3 (1)
Bone Diseases (1) · Bone Diseases, Developmental (1) · Collagen Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Genetic Diseases, Inborn (1) · Musculoskeletal Diseases (1) · Osteochondrodysplasias (1) · Skin and Connective Tissue Diseases (1)
Calcium (1) · Vitamin D (1) · Zoledronic Acid (1) · setrusumab (1)
Ultragenyx Pharmaceutical Inc (1)
Canada (1) · Denmark (1) · France (1) · United Kingdom (1) · United States (1)
2016 (1)